Mobile in Clinical Trials 2021 Reports on A New Era For Patient Connectivity Post Covid-19 from the Conference Forum prweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prweb.com Daily Mail and Mail on Sunday newspapers.
COVID-19 hastened large-scale digital transformation in business schools now we need pandemic-independent innovations that respond to global trends.
To say that education is in a state of transformation is a pandemic-sized understatement. Overnight, entire educational systems have migrated from analog to digital classrooms; suddenly, more than one billion students worldwide are studying online. And yet, a year into the pandemic, one question lingers: Will the future bring more of the same? Now that COVID-19 vaccines have shown us some light at the end of the tunnel, this question looms even larger.
While the pandemic has forced many universities to look inward, we now must take the opposite approach. After interviewing dozens of industry executives on their predictions for the future workforce, we have come to two conclusions: First, our “old normal” is forever gone. The world’s adaptations to the pandemic, higher education’s innovation, and underlying soc
Bringing Clinical Trials To Patients With The Decentralized Model
By Rosamund Round, Vice President, Patient Innovation Center, Parexel®
Before the pandemic, Parexel was experienced at executing decentralized clinical trials to improve patient access and experiences. Since, COVID-19, which has had a huge impact on global clinical trials, sponsors, CROs, sites, and patients have pivoted to adapt to a more home- or community-based approach. More than 100 DCTs later, Parexel is at the forefront of industry change.
“Everything we do is built around the patient and caregiver to make participation as easy as possible.” says Rosamund Round, Vice President of Parexel’s Patient Innovation Center. Central to navigating the dynamic research landscape is Parexel’s ability to harness and apply patient insights during DCT planning to ensure that every part of the strategy is formulated with the patient in mind. This approach, along with expertise in global regulatory requirements, tech